Logo for HOOKIPA Pharma Inc

HOOKIPA Pharma Investor Relations Material

Latest events

Logo for HOOKIPA Pharma Inc

AGM 2024

HOOKIPA Pharma
Logo for HOOKIPA Pharma

Q3 2024

14 Nov, 2024
Logo for HOOKIPA Pharma

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from HOOKIPA Pharma Inc

Access all reports
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company focused on the development of novel immunotherapies for cancer and chronic infectious diseases. The company utilizes a proprietary arenavirus platform, pioneering technologies that engineer arenaviruses to elicit robust and durable antigen-specific T cell responses and pathogen-neutralizing antibodies. HOOKIPA's innovative approach aims to reprogram the immune system to more effectively combat diseases, with its diverse pipeline addressing significant unmet medical needs in various therapeutic areas. The company is headquartered in New York, and its shares are listed on the NASDAQ.